Search
Search Results
##search.searchResults.foundPlural##
-
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1429PDF: 1295HTML: 515 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4946PDF: 2918HTML: 2341 -
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277787PDF: 1846HTML: 3897 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1561PDF: 1810Suppl. Files: 180HTML: 97 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3353PDF: 1579HTML: 475 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9296PDF: 6187HTML: 88056Fig.1b: 216Fig.1c: 222Fig.2a: 204Fig.2b: 201Fig.4: 225Fig.2c: 203Fig.3: 207Tab.1: 261Tab.2: 239Tab.3: 221Tab.4: 252Fig1a: 217 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1786PDF: 1232HTML: 329 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2611PDF: 877HTML: 9055Efremov 1: 252Efremov 2: 215 -
Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy
2889PDF: 794HTML: 1305Blood Count trend before and during lenalidomide treatment: 200Light micrograph of bone marrow biopsy of a patient with PV and 5q deletion: 209 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4113PDF: 1575HTML: 9276Untitled: 302Untitled: 203Untitled: 190Untitled: 186Untitled: 204Untitled: 360 -
DISTRIBUTION OF DIFFERENT PML/RAR? BCR ISOFORMS IN INDIAN ACUTE PROMYELOCYTIC LEUKAEMIA (APL) PATIENTS AND CLINICOHEMATOLOGICAL CORRELATION
1593PDF: 945HTML: 2251Response to reviewers comments: 208 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1735PDF: 826HTML: 876jdoe, table 2 infections CML .doc: 214jdoe, table 1 infections CML .doc: 202 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
2991PDF: 1317HTML: 2833Figure 1: 197 -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2332PDF: 936HTML: 2208 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1720PDF: 1133HTML: 166 -
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
2950PDF: 1145HTML: 3073 -
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1596PDF: 939HTML: 2009Figure: 196Tables: 205ALL revision 1: 292response to reviewer: 199 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3312PDF: 1377HTML: 4151 -
DNA Repair Genes and Chronic Myeloid Leukemia: XPD (751), XRCC1 (399), XRCC4-Intron 3, XRCC4 (1394) Gene Polymorphisms Polymorphisms of DNA Repair Genes in CML
1161PDF: 470HTML: 276 -
Osteolytic bone lesions – A rare presentation of AML M6.
2043PDF: 1155HTML: 7988Untitled: 217 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1407PDF: 611Suppl. Files: 369HTML: 172 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1232PDF: 789HTML: 1527Figure 1: 220Figure 2: 211 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3457PDF: 1514HTML: 4079
1 - 43 of 43 items







